Skip to main content

Security report for amerpharma.com

Amerpharma · Manufacturing · N/a

Medium risk. 8 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

63/100

Risk levelMedium

0–100, higher is better. How it is calculated

Amerpharma is a medium-sized manufacturing and private label company specializing in nutritional supplements, energy gels, syrups, sauces, and natural juices. The company targets health-conscious consumers, athletes, and vegan markets with a diverse product portfolio emphasizing zero sugar, fat free, and vegan-friendly options. The website is built on modern technologies including SvelteKit, Firebase, and Cloudflare DNS, indicating a moderate level of digital maturity. However, the site lacks visible privacy and cookie policies, contact information, and formal security or incident response disclosures, which are important for compliance and trust. Security posture is generally good with HTTPS and domain transfer protection, but DNSSEC is not enabled and security headers are not evident. Overall, the website is professional and content-rich but would benefit from enhanced privacy compliance and security transparency to improve trust and regulatory adherence.

Scanned

NIS2 and GDPR posture

GDPR outside view
35/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

8 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

Need hands-on remediation? Email guard@offseq.com

Keep watching amerpharma.com

This scan found 23 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
75
Security headers
15
Email security
77
DNS health
75
Network security
100
GDPR outside view
35
Average
63

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Amerpharma operates in the manufacturing sector with a focus on health and nutrition products. Their business model centers on private label manufacturing, offering customizable products such as energy gels, syrups, and sauces. The company appears to have a stable market position with a product range catering to niche dietary needs including vegan and sugar-free consumers. The website content and product specifications suggest a well-developed product development and supply chain capability. No explicit partnerships or subsidiaries are identified from the data. The absence of direct contact details on the website may indicate a B2B focus or reliance on direct client relationships offsite.

Security posture

The website employs HTTPS and Cloudflare DNS with domain status clientTransferProhibited, which are positive security indicators. However, DNSSEC is not enabled, and no security headers such as Content-Security-Policy or Strict-Transport-Security are detected in the provided data. There is no public security policy or incident response information, nor a security.txt file for vulnerability disclosure. No exposed sensitive data or vulnerable libraries were identified. The lack of privacy and cookie policies is a compliance gap, especially for GDPR. Overall, the security posture is moderate but could be improved by implementing recommended headers, DNSSEC, and publishing security policies.

Recommendations

  1. Enable DNSSEC on the domain to enhance DNS security and prevent spoofing.
  2. Implement and publish a comprehensive privacy policy and cookie consent mechanism to comply with GDPR and other privacy regulations.
  3. Add security headers such as Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security to improve browser security.
  4. Publish a security policy and incident response contact information, including a security.txt file, to facilitate vulnerability reporting and improve transparency.
  5. Add clear contact information including company emails and phone numbers on the website to improve business credibility and user trust.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Amerpharma
Description
Amerpharma is a manufacturer and private label provider of nutritional supplements, energy gels, syrups, sauces, and natural juices. They offer a wide range of health-oriented products including vegan-friendly, zero sugar, fat free, and reduced calorie options. Their products target health-conscious consumers, athletes, and those seeking dietary supplements.
Key services
Manufacturing of nutritional supplements, Private label product development, Supply of energy gels, syrups, sauces, and natural juices
Content quality
good
Branding
consistent

Technology

Stack
SvelteKit, Cloudflare DNS, Firebase, Algolia, Google Cloud Storage
Frameworks
SvelteKit
Platforms
Firebase
Performance
moderate
Mobile
good
Accessibility
basic
SEO
basic

Security

Observed score
75/100
Good practices seen
  • HTTPS enforced
  • Domain status clientTransferProhibited

Analytics and tracking

Services
Firebase Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
poor

Advertising

Marketing tools
Algolia, Firebase Analytics
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
basic
Professionalism
good
Trustworthiness
moderate

Key observations

  1. Website is accessible with full content
  2. No privacy or cookie policy found on the main page
  3. No contact emails or phone numbers explicitly found in the HTML content
  4. Product catalog is detailed with multiple product lines and specifications
  5. Modern JavaScript framework (SvelteKit) used
  6. No visible security.txt or vulnerability disclosure
  7. No explicit security or incident response policies published
  8. No social media links detected in the provided HTML
  9. Domain uses Cloudflare DNS but DNSSEC is not enabled
Technical notes

Notes

The website is built using the SvelteKit framework, leveraging modern JavaScript modules and cloud services such as Firebase and Google Cloud Storage for hosting media assets. DNS is managed via Cloudflare, providing performance and security benefits, though DNSSEC is not enabled. The site loads multiple CSS and JS chunks asynchronously, indicating a modular and performant frontend architecture. Meta tags and SEO elements are basic but present. Mobile optimization appears good based on viewport settings and responsive CSS. Accessibility features are minimal, with some ARIA attributes detected but no comprehensive accessibility markup. Overall, the technical infrastructure is modern and scalable but could benefit from enhanced SEO and accessibility improvements.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with amerpharma.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review amerpharma.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.